VitalMedix Inc. engages in the research and development of biopharmaceuticals for sustaining cellular function and protecting cells during
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Minneapolis
State: Minnesota
Zip:
Country: United States
VitalMedix Inc. engages in the research and development of biopharmaceuticals for sustaining cellular function and protecting cells during and after hemorrhagic shock in the United States. The company develops Tamiasyn, a biopharmaceutical that potentially allows the human body to endure severe blood loss for an extended period of time, as well as inhibits human organ damage during the resuscitation process. It also develops a hemorrhagic shock treatment system. The company was founded in 2005 and is based in Minneapolis, Minnesota.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2009 | Venture Round | 5 | $1M |
Capital Midwest Fund Silicon Pastures St. Croix Valley Angel Network Successful Entrepreneur Investors (SEI) Wisconsin Investment Partners Capital Midwest Fund Silicon Pastures St. Croix Valley Angel Network Successful Entrepreneur Investors (SEI) Wisconsin Investment Partners |
6/2009 | Debt Financing | $100k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|